Bladder cancer remains the ninth most common cancer worldwide. Many of the risk factors associated with bladder cancer are acquired and are therefore modifiable. This study aimed to systematically review the literature to identify the main acquired risk factors associated with the development of bladder cancer.
Methods:
We performed a meticulous, systematic literature review for relevant studies using two electronic databases PubMed and Medline. Studies deemed eligible examined bladder cancer risk factors and were published in the English language.
Results:
One hundred and twenty-five full-text articles were included in the review. The majority were case–control studies and cohort studies, with some systematic reviews and meta-analyses included. The acquired risk factors which were most commonly identified include smoking, occupational exposures, dietary factors and medical conditions.
Conclusion:
Bladder cancer remains a disease with a significant global burden, much of which can be attributable to modifiable and acquired risk factors. A key factor in the primary prevention of bladder cancer is the identification and modification of these risk factors by both physicians and patients.
SievertKDAmendBNageleU, et al. Economic aspects of bladder cancer: what are the benefits and costs. World J Urol2009; 27(3): 295–300.
2.
RichtersAAbenKKHKiemeneyLALM. The global burden of urinary bladder cancer: an update. World J Urol2020; 38(8): 1895–1904.
3.
CumberbatchMGKJubberIBlackPC, et al. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol2018; 74(6): 784–795.
4.
MalatsNRealFX.Epidemiology of bladder cancer. Hematol Oncol Clin North Am2015; 29(2): 177vii–89.
5.
Al-HusseiniMJKunbazASaadAM, et al. Trends in the incidence and mortality of transitional cell carcinoma of the bladder for the last four decades in the USA: a SEER-based analysis. BMC Cancer2019; 19(1): 46.
6.
BabjukMBöhleABurgerM, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol2017; 71(3): 447–461.
7.
Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol2005; 48(2): 202–205; discussion 205–206.
8.
JubberIShariatSFConroyS, et al. Non-visible haematuria for the detection of bladder, upper tract, and kidney cancer: an updated systematic review and meta-analysis. Eur Urol2020; 77(5): 583–598.
9.
BurgerMCattoJWDalbagniG, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol2013; 63(2): 234–241.
10.
CumberbatchMGRotaMCattoJW, et al. The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks. Eur Urol2016; 70(3): 458–466.
11.
WardECarpenterAMarkowitzS, et al. Excess number of bladder cancers in workers exposed to ortho-toluidine and aniline. J Natl Cancer Inst1991; 83(7): 501–506.
12.
WeinbergDMRossRKMackTM, et al. Bladder cancer etiology. A different perspective. Cancer1983; 51(4): 675–680.
13.
VineisPSegnanNCostaG, et al. Evidence of a multiplicative effect between cigarette smoking and occupational exposures in the aetiology of bladder cancer. Cancer Lett1981; 14(3): 285–290.
14.
GoebellPJVillanuevaCMRettenmeierAW, et al. Environmental exposure, chlorinated drinking water, and bladder cancer. World J Urol2004; 21(6): 424–432.
15.
GuhaNSteenlandNKMerlettiF, et al. Bladder cancer risk in painters: a meta-analysis. Occup Environ Med2010; 67(8): 568–573.
16.
HadkhaleKMartinsenJIWeiderpassE, et al. Occupational variation in bladder cancer in Nordic males adjusted with approximated smoking prevalence. Acta Oncol2019; 58(1): 29–37.
17.
SheridanAO’FarrellAEvansD, et al. Adult smoking in Ireland: a special analysis of the Healthy Ireland Survey and The Irish Longitudinal Study on Ageing (TILDA), 2018, https://www.drugsandalcohol.ie/29203/
18.
CreamerMRWangTWBabbS, et al. Tobacco product use and cessation indicators among adults – United States, 2018. MMWR Morb Mortal Wkly Rep2019; 68(45): 1013–1019.
19.
GabrielULiLBolenzC, et al. New insights into the influence of cigarette smoking on urothelial carcinogenesis: smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer. Mol Carcinog2012; 51(11): 907–915.
20.
FreedmanNDSilvermanDTHollenbeckAR, et al. Association between smoking and risk of bladder cancer among men and women. JAMA2011; 306(7): 737–745.
21.
van OschFHJochemsSHvan SchootenFJ, et al. Quantified relations between exposure to tobacco smoking and bladder cancer risk: a meta-analysis of 89 observational studies. Int J Epidemiol2016; 45(3): 857–870.
22.
MoolgavkarSHStevensRG.Smoking and cancers of bladder and pancreas: risks and temporal trends. J Natl Cancer Inst1981; 67(1): 15–23.
LammersRJWitjesWPHendricksenK, et al. Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer. Eur Urol2011; 60(4): 713–720.
25.
WynderELHoffmannD.Smoking and lung cancer: scientific challenges and opportunities. Cancer Res1994; 54(20): 5284–5295.
26.
HoffmannDHoffmannIEl-BayoumyK.The less harmful cigarette: a controversial issue. Chem Res Toxicol2001; 14(7): 767–790.
27.
GaertnerRRTrpeskiLJohnsonKC.A case-control study of occupational risk factors for bladder cancer in Canada. Cancer Causes Control2004; 15(10): 1007–1019.
28.
FerreccioCYuanYCalleJ, et al. Arsenic, tobacco smoke, and occupation: associations of multiple agents with lung and bladder cancer. Epidemiology2013; 24(6): 898–905.
29.
FerrísJBerbelOAlonso-LópezJ, et al. Environmental non-occupational risk factors associated with bladder cancer. Actas Urol Esp2013; 37(9): 579–586.
30.
ZeegersMPSwaenGMKantI, et al. Occupational risk factors for male bladder cancer: results from a population-based case cohort study in the Netherlands. Occup Environ Med2001; 58(9): 590–596.
31.
SturgeonSRHartgePSilvermanDT, et al. Associations between bladder cancer risk factors and tumor stage and grade at diagnosis. Epidemiology1994; 5(2): 218–225.
32.
Escolar PujolarAGonzálezCALópez-AbenteG, et al. Bladder cancer and coffee consumption in smokers and non-smokers in Spain. Int J Epidemiol1993; 22(1): 38–44.
33.
OţeleaMRJingaVRaşcuAŞC, et al. Occupational exposure to urinary bladder carcinogens – risk factors, molecular mechanisms and biomarkers. Rom J Morphol Embryol2018; 59(4): 1021–1032.
34.
CumberbatchMGCoxATeareD, et al. Contemporary occupational carcinogen exposure and bladder cancer: a systematic review and meta-analysis. JAMA Oncol2015; 1(9): 1282–1290.
35.
YuMCSkipperPLTannenbaumSR, et al. Arylamine exposures and bladder cancer risk. Mutat Res2002; 506–507: 21–28.
36.
DollRPetoR.The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst1981; 66(6): 1191–1308.
37.
MorrisonASAhlbomAVerhoekWG, et al. Occupation and bladder cancer in Boston, USA, Manchester, UK, and Nagoya, Japan. J Epidemiol Community Health1985; 39(4): 294–300.
38.
MiyazakiJNishiyamaH.Epidemiology of urothelial carcinoma. Int J Urol2017; 24(10): 730–734.
39.
CassidyAWangWWuX, et al. Risk of urinary bladder cancer: a case-control analysis of industry and occupation. BMC Cancer2009; 9: 443.
40.
NomuraAKolonelLNYoshizawaCN.Smoking, alcohol, occupation, and hair dye use in cancer of the lower urinary tract. Am J Epidemiol1989; 130(6): 1159–1163.
41.
NoonAPMartinsenJICattoJFW, et al. Occupation and bladder cancer phenotype: identification of workplace patterns that increase the risk of advanced disease beyond overall incidence. Eur Urol Focus2018; 4(5): 725–730.
42.
GlashanRWCartwrightRA.Occupational bladder cancer and cigarette smoking in West Yorkshire. Br J Urol1981; 53(6): 602–604.
43.
RosMMGago-DominguezMAbenKK, et al. Personal hair dye use and the risk of bladder cancer: a case-control study from The Netherlands. Cancer Causes Control2012; 23(7): 1139–1148.
44.
DrysonE‘t MannetjeAWallsC, et al. Case-control study of high risk occupations for bladder cancer in New Zealand. Int J Cancer2008; 122(6): 1340–1346.
45.
TeschkeKMorganMSCheckowayH, et al. Surveillance of nasal and bladder cancer to locate sources of exposure to occupational carcinogens. Occup Environ Med1997; 54(6): 443–451.
46.
BrownTSlackRRushtonL.Occupational cancer in Britain. Urinary tract cancers: bladder and kidney. Br J Cancer. 2012;107(suppl 1):S76–S84.
47.
BachandAMundtKAMundtDJ, et al. Meta-analyses of occupational exposure as a painter and lung and bladder cancer morbidity and mortality 1950-2008. Crit Rev Toxicol2010; 40(2): 101–125.
48.
MannetjeAKogevinasMChang-ClaudeJ, et al. Occupation and bladder cancer in European women. Cancer Causes Control1999; 10(3): 209–217.
49.
VillanuevaCMSilvermanDTMalatsN, et al. Determinants of quality of interview and impact on risk estimates in a case-control study of bladder cancer. Am J Epidemiol2009; 170(2): 237–243.
50.
WilkensLRKadirMMKolonelLN, et al. Risk factors for lower urinary tract cancer: the role of total fluid consumption, nitrites and nitrosamines, and selected foods. Cancer Epidemiol Biomarkers Prev1996; 5(3): 161–166.
51.
KabatGCDieckGSWynderEL.Bladder cancer in nonsmokers. Cancer1986; 57(2): 362–367.
52.
HoweGRBurchJDMillerAB, et al. Tobacco use, occupation, coffee, various nutrients, and bladder cancer. J Natl Cancer Inst1980; 64(4): 701–713.
53.
MichaudDSKogevinasMCantorKP, et al. Total fluid and water consumption and the joint effect of exposure to disinfection by-products on risk of bladder cancer. Environ Health Perspect2007; 115(11): 1569–1572.
54.
PohlabelnHJöckelKHBolm-AudorffU.Non-occupational risk factors for cancer of the lower urinary tract in Germany. Eur J Epidemiol1999; 15(5): 411–419.
55.
VillanuevaCMCantorKPKingWD, et al. Total and specific fluid consumption as determinants of bladder cancer risk. Int J Cancer2006; 118(8): 2040–2047.
56.
KunzeEChang-ClaudeJFrentzel-BeymeR.Life style and occupational risk factors for bladder cancer in Germany. A case-control study. Cancer1992; 69(7): 1776–1790.
57.
SalaMCordierSChang-ClaudeJ, et al. Coffee consumption and bladder cancer in nonsmokers: a pooled analysis of case-control studies in European countries. Cancer Causes Control2000; 11(10): 925–931.
58.
Murta-NascimentoCSchmitz-DrägerBJZeegersMP, et al. Epidemiology of urinary bladder cancer: from tumor development to patient’s death. World J Urol2007; 25(3): 285–295.
59.
LoomisDGuytonKZGrosseY, et al. Carcinogenicity of drinking coffee, mate, and very hot beverages. Lancet Oncol2016; 17(7): 877–878.
60.
ProbertJLPersadRAGreenwoodRP, et al. Epidemiology of transitional cell carcinoma of the bladder: profile of an urban population in the south-west of England. Br J Urol1998; 82(5): 660–666.
61.
PelucchiCBosettiCNegriE, et al. Mechanisms of disease: the epidemiology of bladder cancer. Nat Clin Pract Urol2006; 3(6): 327–340.
62.
KwanMLGarrenBNielsenME, et al. Lifestyle and nutritional modifiable factors in the prevention and treatment of bladder cancer. Urol Oncol2019; 37(6): 380–386.
63.
TesterJ.Coffee, mate, and very hot beverages – an update on carcinogenic risk. Aust J Herbal Med2016; 28: 95.
64.
YaoBYanYYeX, et al. Intake of fruit and vegetables and risk of bladder cancer: a dose-response meta-analysis of observational studies. Cancer Causes Control2014; 25(12): 1645–1658.
65.
JakszynPGonzálezCALuján-BarrosoL, et al. Red meat, dietary nitrosamines, and heme iron and risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev2011; 20(3): 555–559.
66.
LiFAnSHouL, et al. Red and processed meat intake and risk of bladder cancer: a meta-analysis. Int J Clin Exp Med2014; 7(8): 2100–2110.
67.
SteinmausCMNuñezSSmithAH.Diet and bladder cancer: a meta-analysis of six dietary variables. Am J Epidemiol2000; 151(7): 693–702.
68.
ZaitsuMNakamuraFToyokawaS, et al. Risk of alcohol consumption in bladder cancer: case-control study from a nationwide inpatient database in Japan. Tohoku J Exp Med2016; 239(1): 9–15.
69.
BotteriEFerrariPRoswallN, et al. Alcohol consumption and risk of urothelial cell bladder cancer in the European prospective investigation into cancer and nutrition cohort. Int J Cancer2017; 141(10): 1963–1970.
70.
ChangCHLiuCSLiuHJ, et al. Association between levels of urinary heavy metals and increased risk of urothelial carcinoma. Int J Urol2016; 23(3): 233–239.
71.
LetašiováSMedve’ováAŠovčíkováA, et al. Bladder cancer, a review of the environmental risk factors. Environ Health2012;11(suppl 1): S11.
72.
NesiGGalliICAmorosiA, et al. Environment and urinary bladder cancer. A historical perspective. Pol J Pathol2019; 70(1): 21–25.
73.
Hopenhayn-RichCBiggsMLFuchsA, et al. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology1996; 7(2): 117–124.
74.
Saint-JacquesNParkerLBrownP, et al. Arsenic in drinking water and urinary tract cancers: a systematic review of 30 years of epidemiological evidence. Environ Health2014; 13: 44.
WallisCJMaharALChooR, et al. Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis. BMJ2016; 352: i851.
77.
FerwanaMFirwanaBHasanR, et al. Pioglitazone and the risk of bladder cancer: a meta-analysis. Diabetes Ther2017; 8(4): 705–726.
78.
RavaMCzachorowskiMJSilvermanD, et al. Asthma status is associated with decreased risk of aggressive urothelial bladder cancer. Int J Cancer2018; 142(3): 470–476.
79.
Al-ZalabaniAHStewartKFWesseliusA, et al. Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses. Eur J Epidemiol2016; 31(9): 811–851.
80.
PannelliFLa RosaFSaltalamacchiaG, et al. Tobacco smoking, coffee, cocoa and tea consumption in relation to mortality from urinary bladder cancer in Italy. Eur J Epidemiol1989; 5(3): 392–397.
81.
NiederAMJohnSMessinaCR, et al. Are patients aware of the association between smoking and bladder cancer. J Urol2006; 176(6, Pt 1): 2405–2408; discussion 2408.
82.
WesthoffEMariadeOliveira-NeumayerJAbenKK, et al. Low awareness of risk factors among bladder cancer survivors: New evidence and a literature overview. Eur J Cancer2016; 60: 136–145.
83.
FleshnerNGarlandJMoadelA, et al. Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer1999; 86(11): 2337–2345.
84.
WilcoxANSilvermanDTFriesenMC, et al. Smoking status, usual adult occupation, and risk of recurrent urothelial bladder carcinoma: data from The Cancer Genome Atlas (TCGA) Project. Cancer Causes Control2016; 27(12): 1429–1435.
85.
StarkeNSinglaNHaddadA, et al. Long-term outcomes in a high-risk bladder cancer screening cohort. BJU Int2016; 117(4): 611–617.
86.
Ouellet-HellstromRRenchJD.Bladder cancer incidence in arylamine workers. J Occup Environ Med1996; 38(12): 1239–1247.
87.
ShiraiTFradetYHulandH, et al. The etiology of bladder cancer – are there any new clues or predictors of behavior?Int J Urol1995; 2(Suppl 2): 64–75.
88.
National Collaborating Centre for Cancer. National Institute for Health and Care Excellence: Clinical Guidelines, in Suspected Cancer: Recognition and Referral. London: National Institute for Health and Care Excellence, 2015.
89.
ColtJSBarisDStewartP, et al. Occupation and bladder cancer risk in a population-based case-control study in New Hampshire. Cancer Causes Control2004; 15(8): 759–769.
90.
ColtJSKaragasMRSchwennM, et al. Occupation and bladder cancer in a population-based case-control study in Northern New England. Occup Environ Med2011; 68(4): 239–249.
91.
CordierSClavelJLimassetJC, et al. Occupational risks of bladder cancer in France: a multicentre case-control study. Int J Epidemiol1993; 22(3): 403–411.
92.
ClavelJMandereauLLimassetJC, et al. Occupational exposure to polycyclic aromatic hydrocarbons and the risk of bladder cancer: a French case-control study. Int J Epidemiol1994; 23(6): 1145–1153.
93.
ColinRGrzebykMWildP, et al. Bladder cancer and occupational exposure to metalworking fluid mist: a counter-matched case-control study in French steel-producing factories. Occup Environ Med2018; 75(5): 328–336.
94.
D’AvanzoBNegriELa VecchiaC, et al. Cigarette smoking and bladder cancer. Eur J Cancer1990; 26(6): 714–718.
95.
De StefaniEBoffettaPDeneo-PellegriniH, et al. Non-alcoholic beverages and risk of bladder cancer in Uruguay. BMC Cancer2007; 7: 57.
96.
BurnsPBSwansonGM.Risk of urinary bladder cancer among Blacks and Whites: the role of cigarette use and occupation. Cancer Causes Control1991; 2(6): 371–379.
97.
SchairerCHartgePHooverRN, et al. Racial differences in bladder cancer risk: a case-control study. Am J Epidemiol1988; 128(5): 1027–1037.
98.
ProutGRJrWesleyMNGreenbergRS, et al. Bladder cancer: race differences in extent of disease at diagnosis. Cancer2000; 89(6): 1349–1358.
99.
HartgePSilvermanDTSchairerC, et al. Smoking and bladder cancer risk in blacks and whites in the United States. Cancer Causes Control1993; 4(4): 391–394.
100.
BoykoRWCartwrightRAGlashanRW.Bladder cancer in dye manufacturing workers. J Occup Med1985; 27(11): 799–803.
101.
BrooksDRGellerACChangJ, et al. Occupation, smoking, and the risk of high-grade invasive bladder cancer in Missouri. Am J Ind Med1992; 21(5): 699–713.
102.
BonassiSMerloFPearceN, et al. Bladder cancer and occupational exposure to polycyclic aromatic hydrocarbons. Int J Cancer1989; 44(4): 648–651.
103.
BandPRLeNDMacArthurAC, et al. Identification of occupational cancer risks in British Columbia: a population-based case-control study of 1129 cases of bladder cancer. J Occup Environ Med2005; 47(8): 854–858.
104.
Anton-CulverHLee-FeldsteinATaylorTH.Occupation and bladder cancer risk. Am J Epidemiol1992; 136(1): 89–94.
105.
KogevinasM‘t MannetjeACordierS, et al. Occupation and bladder cancer among men in Western Europe. Cancer Causes Control2003; 14(10): 907–914.
106.
BachirBGKassoufW.Cause-effect? Understanding the risk factors associated with bladder cancer. Expert Rev Anticancer Ther2012; 12(12): 1499–1502.
107.
Anton-CulverHLee-FeldsteinATaylorTH.The association of bladder cancer risk with ethnicity, gender, and smoking. Ann Epidemiol1993; 3(4): 429–433.
108.
BoulangerMTualSLemarchandC, et al. Agricultural exposure and risk of bladder cancer in the AGRIculture and CANcer cohort. Int Arch Occup Environ Health2017; 90(2): 169–178.
109.
MarrettLDHartgePMeigsJW.Bladder cancer and occupational exposure to leather. Br J Ind Med1986; 43(2): 96–100.
110.
MallinK.A nested case-control study of bladder cancer incidence in a steel manufacturing plant. Am J Ind Med1998; 34(4): 393–398.
111.
BiWHayesRBFengP, et al. Mortality and incidence of bladder cancer in benzidine-exposed workers in China. Am J Ind Med1992; 21(4): 481–489.
112.
KoutrosSSilvermanDTAlavanjaMC, et al. Occupational exposure to pesticides and bladder cancer risk. Int J Epidemiol2016; 45(3): 792–805.
